91 related articles for article (PubMed ID: 3795641)
1. [Serum squamous cell carcinoma-related antigen in lung cancer--a marker for the extent of the disease and response to therapy].
Reshad K; Inui K; Takahashi Y; Itoi K; Nakano Y; Sakamoto M; Suzuki K
Nihon Kyobu Shikkan Gakkai Zasshi; 1986 Aug; 24(8):878-83. PubMed ID: 3795641
[No Abstract] [Full Text] [Related]
2. [Clinical study on the measurement of squamous cell carcinoma (SCC)--related antigen in SCC].
Fukunaga M; Otsuka N; Sone T; Nagai K; Muranaka A; Furukawa T; Yanagi M; Yanagimoto S; Tomomitsu T; Morita R
Gan No Rinsho; 1985 Dec; 31(15):1885-8. PubMed ID: 3842935
[TBL] [Abstract][Full Text] [Related]
3. [Clinical significance of serum SCC Ag in patients with squamous cell carcinoma of the lung].
Zeng L
Zhonghua Wai Ke Za Zhi; 1993 Mar; 31(3):143-5. PubMed ID: 8223022
[TBL] [Abstract][Full Text] [Related]
4. [The measurement of SCC antigen in squamous cell carcinoma of the lung].
Masuoka T; Matueda Y; Ookawa H; Watanabe K; Mimoto S
Gan No Rinsho; 1985 Jul; 31(8):914-8. PubMed ID: 4032769
[TBL] [Abstract][Full Text] [Related]
5. Utility of the serum tumor markers: CYFRA 21.1, carcinoembryonic antigen (CEA), and squamous cell carcinoma antigen (SCC) in squamous cell lung cancer.
Tas F; Aydiner A; Topuz E; Yasasever V; Karadeniz A; Saip P
J Exp Clin Cancer Res; 2000 Dec; 19(4):477-81. PubMed ID: 11277326
[TBL] [Abstract][Full Text] [Related]
6. [Clinical evaluation of serum beta 2-microglobulin in squamous cell carcinoma of the lung].
Higuchi Y; Togawa T; Moriya H; Hoshi K; Satoh T; Kimura K
Gan No Rinsho; 1986 Dec; 32(15):1919-24. PubMed ID: 3543434
[TBL] [Abstract][Full Text] [Related]
7. [An immunoradiometric assay of serum SCC antigen using a monoclonal antibody--a comparison with the conventional double antibody method].
Mino N; Iio A; Ata M; Hamamoto K
Gan No Rinsho; 1988 Mar; 34(3):321-5. PubMed ID: 3357252
[TBL] [Abstract][Full Text] [Related]
8. [An expression of an SCC antigen in oral cancer].
Tsuji T; Sasaki K; Matsumura K; Tanaka K; Kawasaki M; Nakashima K; Takahashi M; Shinozaki F
Gan No Rinsho; 1987 Dec; 33(15):1875-8. PubMed ID: 3430739
[TBL] [Abstract][Full Text] [Related]
9. Cytokeratin 19 fragment CYFRA 21-1 compared with carcinoembryonic antigen, squamous cell carcinoma antigen and neuron-specific enolase in lung cancer. Results of an international multicentre study.
Ebert W; Dienemann H; Fateh-Moghadam A; Scheulen M; Konietzko N; Schleich T; Bombardieri E
Eur J Clin Chem Clin Biochem; 1994 Mar; 32(3):189-99. PubMed ID: 7518259
[TBL] [Abstract][Full Text] [Related]
10. Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinoma.
Shimada H; Nabeya Y; Okazumi S; Matsubara H; Shiratori T; Gunji Y; Kobayashi S; Hayashi H; Ochiai T
Surgery; 2003 May; 133(5):486-94. PubMed ID: 12773976
[TBL] [Abstract][Full Text] [Related]
11. Squamous cell carcinoma antigen: clinical utility in squamous cell carcinoma of the uterine cervix.
Bolli JA; Doering DL; Bosscher JR; Day TG; Rao CV; Owens K; Kelly B; Goldsmith J
Gynecol Oncol; 1994 Nov; 55(2):169-73. PubMed ID: 7959279
[TBL] [Abstract][Full Text] [Related]
12. Tissue microarray evaluation of Melanoma antigen E (MAGE) tumor-associated antigen expression: potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinoma.
Bolli M; Kocher T; Adamina M; Guller U; Dalquen P; Haas P; Mirlacher M; Gambazzi F; Harder F; Heberer M; Sauter G; Spagnoli GC
Ann Surg; 2002 Dec; 236(6):785-93; discussion 793. PubMed ID: 12454517
[TBL] [Abstract][Full Text] [Related]
13. Immunohystochemical expression of cancer/testis antigens (MAGE-A3/4, NY-ESO-1) in non-small cell lung cancer: the relationship with clinical-pathological features.
Grah J; Samija M; Juretić A; Sarcević B; Sobat H
Coll Antropol; 2008 Sep; 32(3):731-6. PubMed ID: 18982744
[TBL] [Abstract][Full Text] [Related]
14. [Squamous cell carcinoma related antigen in serum of the patients with esophageal carcinoma].
Kitamura M; Matsuda H; Matsuura H; Kai H; Ageo H; Sugimachi K
Nihon Geka Gakkai Zasshi; 1985 Nov; 86(11):1561. PubMed ID: 4079908
[No Abstract] [Full Text] [Related]
15. Tumour-associated antigens in lung cancer: the possibility for a serologic assay.
Kelly BS; Levy JG
Can Med Assoc J; 1980 May; 122(9):1020-3. PubMed ID: 7370881
[TBL] [Abstract][Full Text] [Related]
16. Fuzzy logic-based tumor marker profiles including a new marker tumor M2-PK improved sensitivity to the detection of progression in lung cancer patients.
Schneider J; Peltri G; Bitterlich N; Neu K; Velcovsky HG; Morr H; Katz N; Eigenbrodt E
Anticancer Res; 2003; 23(2A):899-906. PubMed ID: 12820320
[TBL] [Abstract][Full Text] [Related]
17. [Clinical evaluation of serum squamous cell carcinoma-related antigen levels in patients with malignant neoplasms].
Jinnouchi S; Hoshi H; Mori Y; Harada K; Onoe K; Nagamachi S; Futami S; Ebihara H; Watanabe K; Tahara Y
Radioisotopes; 1986 Dec; 35(12):642-4. PubMed ID: 3823498
[No Abstract] [Full Text] [Related]
18. [Increase of squamous cell carcinoma antigen in 2 patients with erythroderma].
Kaplanski G; Deharo C; De Boissezon C; Koeppel MC; Angeli C; Sayag J
Ann Dermatol Venereol; 1992; 119(8):575. PubMed ID: 1485762
[No Abstract] [Full Text] [Related]
19. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.
Juang CM; Wang PH; Yen MS; Lai CR; Ng HT; Yuan CC
Gynecol Oncol; 2000 Jan; 76(1):103-6. PubMed ID: 10620449
[TBL] [Abstract][Full Text] [Related]
20. [SCC-antigen in patients with lung cancer].
Matsubara Y; Yasuda Y; Hanawa T; Miyamoto Y; Ninomiya K; Hatakenaka R; Funatsu T; Ikeda S
Nihon Gan Chiryo Gakkai Shi; 1986 Jun; 21(5):1036-48. PubMed ID: 3760648
[No Abstract] [Full Text] [Related]
[Next] [New Search]
